The market is driving prices on GLP-1 drugs down, and an added benefit is lower spending on food.

Weight loss and diabetes drugs on the market often do not achieve long-term weight loss for patients. GLP-1 drugs target ...

Novo Nordisk remains a strong buy despite share price dip, thanks to its robust drug pipeline, massive market potential, and ...

Eli Lilly and Novo Nordisk are actively exploring other medical uses for their GLP-1 drugs, and have already seen some ...

A new drug that skips neurons and targets support cells cut weight and improved insulin response in lab animals, without ...

Wegovy and Zepbound - except the weight regain is worse, because of the extreme way in which these medications suppress your ...

In their zeal to “Make America Healthy Again,” Trump administration officials are making statements that some advocacy and ...

Dear E.M.: Obstructive sleep apnea is when a person stops breathing during sleep due to obstruction of their airway. Some ...

This maker of weight-loss drugs saw its share price zoom and then crash. The CEO has been replaced. The incoming boss will ...

Hims & Hers Health stock fell as much as 5% early Tuesday after the company reported revenue late Monday that fell shy of ...

Dr. Tim Church predicted recently that GLP-1 agonists, GLP-1 /GIP agonists and similar prescription drugs will soon be as ...

Novo Nordisk underestimated the impact of competition from personalized compounded drugs when providing sales estimates for ...